A H Lazarus
Overview
Explore the profile of A H Lazarus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, et al.
Scand J Immunol
. 2018 Jun;
88(1):e12678.
PMID: 29855061
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by increased peripheral immune platelet destruction and megakaryocyte defects in the bone marrow. Although ITP was originally thought to be primarily...
2.
Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders
Imbach P, Lazarus A, Kuhne T
Vox Sang
. 2009 Oct;
98(3 Pt 2):385-94.
PMID: 19821958
The increase in platelets in patients with immune thrombocytopenia (ITP) by intravenous administration of human immunoglobulin concentrates (IVIG) reflects a therapeutic immunomodulatory intervention targeted at the disturbed immune response in...
3.
Crow A, Brinc D, Lazarus A
J Thromb Haemost
. 2009 Jul;
7 Suppl 1:245-8.
PMID: 19630809
Intravenous immunoglobulin (IVIg) is used to treat an ever-increasing number of autoimmune diseases. While the exact mechanism of action of IVIg has remained elusive, many theories have been suggested, including...
4.
Song S, Mody M, Freedman J, Ellis J, Lazarus A
J Thromb Haemost
. 2003 Jul;
1(2):337-46.
PMID: 12871509
The interaction between von Willebrand factor (VWF) and glycoprotein (GP) Ib results in platelet agglutination and activation of many signaling intermediates. To determine if VWF-dependent platelet activation requires the participation...
5.
Crow A, Leytin V, Starkey A, Rand M, Lazarus A
J Thromb Haemost
. 2003 Jul;
1(4):850-2.
PMID: 12871426
No abstract available.
6.
Freedman J, Mody M, Lazarus A, Dewar L, Song S, Blanchette V, et al.
Am J Hematol
. 2002 Mar;
69(3):192-9.
PMID: 11891806
Activation of platelets and coagulation in vivo was studied in nine patients with hemophilia A and inhibitors to human Factor VIII, prior to and following treatment with porcine Factor VIII...
7.
Crow A, Song S, Semple J, Freedman J, Lazarus A
Br J Haematol
. 2001 Dec;
115(3):679-86.
PMID: 11736954
Although the mechanism of action of intravenous immunoglobulin (IVIg) in treating antibody-dependent thrombocytopenia remains unclear, most studies have suggested that IVIg blocks the function of Fc receptors in the reticuloendothelial...
8.
Crow A, Freedman J, Hannach B, Lazarus A
Br J Haematol
. 2000 Sep;
110(2):481-7.
PMID: 10971412
Presensitization of donor platelets with allo-specific immunoglobulin (Ig)G results in a diminished immune response against subsequent transfusions of platelets. To understand better the mechanism of how alloantibody presensitization results in...
9.
Song S, Freedman J, Mody M, Lazarus A
Br J Haematol
. 2000 Aug;
109(4):851-6.
PMID: 10929041
The interaction of platelets with subendothelial von Willebrand factor (VWF), especially under high shear stress, is considered to be the first activation step which primes platelets for subsequent haemostatic events....
10.
Lazarus A, Ellis J, Semple J, Mody M, Crow A, Freedman J
Transfus Sci
. 2000 Apr;
22(1-2):19-27.
PMID: 10771375
Idiopathic thrombocytopenic purpura (ITP) is characterized by the development of a specific anti-platelet autoantibody immune response mediating the development of thrombocytopenia. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized...